6-K//Foreign company update
Altamira Therapeutics Ltd. 6-K
Accession 0001213900-24-080300
$CYTOFCIK 0001601936other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:17 PM ET
Size
727.9 KB
Accession
0001213900-24-080300
Documents
- 6-Kea0215114-6k_altamira.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
- EX-4.1ea021511401ex4-1_altamira.htm
FORM OF PRE-FUNDED WARRANT
- EX-4.2ea021511401ex4-2_altamira.htm
FORM OF SERIES A-1 WARRANT
- EX-4.3ea021511401ex4-3_altamira.htm
FORM OF SERIES A-2 WARRANT
- EX-4.4ea021511401ex4-4_altamira.htm
FORM OF PLACEMENT AGENT WARRANT
- EX-10.1ea021511401ex10-1_altamira.htm
FORM OF SECURITIES PURCHASE AGREEMENT
- EX-10.2ea021511401ex10-2_altamira.htm
FORM OF WARRANT AMENDMENT
- EX-99.1ea021511401ex99-1_altamira.htm
PRESS RELEASE, DATED SEPTEMBER 17, 2024
- EX-99.2ea021511401ex99-2_altamira.htm
PRESS RELEASE, DATED SEPTEMBER 19, 2024
Issuer
Altamira Therapeutics Ltd.
CIK 0001601936
Entity typeother
IncorporatedBermuda
Related Parties
1- filerCIK 0001601936
Filing Metadata
- Form type
- 6-K
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:17 PM ET
- Size
- 727.9 KB